[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CL2013000578A1 - Sal cristalina de sodio del acido (e)-3-[2-(1-{[2-(5-bromo-pririmidin-2-il)-3-ciclopentil-1-metil-1h-indol-6-carbonil]-amino}-ciclobutil)-3-metil-3h-bencimidazol-5-il]-acrilico: sal amorfa;compuestos intermediarios; procedimientos de preparacion; composicion farmaceutica. - Google Patents

Sal cristalina de sodio del acido (e)-3-[2-(1-{[2-(5-bromo-pririmidin-2-il)-3-ciclopentil-1-metil-1h-indol-6-carbonil]-amino}-ciclobutil)-3-metil-3h-bencimidazol-5-il]-acrilico: sal amorfa;compuestos intermediarios; procedimientos de preparacion; composicion farmaceutica.

Info

Publication number
CL2013000578A1
CL2013000578A1 CL2013000578A CL2013000578A CL2013000578A1 CL 2013000578 A1 CL2013000578 A1 CL 2013000578A1 CL 2013000578 A CL2013000578 A CL 2013000578A CL 2013000578 A CL2013000578 A CL 2013000578A CL 2013000578 A1 CL2013000578 A1 CL 2013000578A1
Authority
CL
Chile
Prior art keywords
methyl
pririmidin
benzimidazol
acryl
indole
Prior art date
Application number
CL2013000578A
Other languages
English (en)
Inventor
Rolf-Stefan Brickl
Shirlynn Chen
Jihchin Chung
Mayur Suryakant Dudhedia
Danping Li
Zhi-Hui Lu
Siddharthya Mujumdar
Chitra Telang
Richard J Varsolona
Zeren Wang
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44759789&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013000578(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2013000578A1 publication Critical patent/CL2013000578A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CL2013000578A 2010-09-30 2013-02-28 Sal cristalina de sodio del acido (e)-3-[2-(1-{[2-(5-bromo-pririmidin-2-il)-3-ciclopentil-1-metil-1h-indol-6-carbonil]-amino}-ciclobutil)-3-metil-3h-bencimidazol-5-il]-acrilico: sal amorfa;compuestos intermediarios; procedimientos de preparacion; composicion farmaceutica. CL2013000578A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38824210P 2010-09-30 2010-09-30

Publications (1)

Publication Number Publication Date
CL2013000578A1 true CL2013000578A1 (es) 2013-08-02

Family

ID=44759789

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013000578A CL2013000578A1 (es) 2010-09-30 2013-02-28 Sal cristalina de sodio del acido (e)-3-[2-(1-{[2-(5-bromo-pririmidin-2-il)-3-ciclopentil-1-metil-1h-indol-6-carbonil]-amino}-ciclobutil)-3-metil-3h-bencimidazol-5-il]-acrilico: sal amorfa;compuestos intermediarios; procedimientos de preparacion; composicion farmaceutica.

Country Status (21)

Country Link
US (2) US8598183B2 (es)
EP (1) EP2621921A1 (es)
JP (1) JP2013543495A (es)
KR (1) KR20130108326A (es)
CN (1) CN103153987A (es)
AP (1) AP2013006733A0 (es)
AR (1) AR083256A1 (es)
AU (1) AU2011307346A1 (es)
BR (1) BR112013007700A2 (es)
CA (1) CA2813179A1 (es)
CL (1) CL2013000578A1 (es)
CO (1) CO6700844A2 (es)
EA (1) EA201300422A1 (es)
EC (1) ECSP13012552A (es)
MA (1) MA34548B1 (es)
MX (1) MX2013003551A (es)
PE (1) PE20131351A1 (es)
SG (1) SG188376A1 (es)
TW (1) TW201307327A (es)
UY (1) UY33632A (es)
WO (1) WO2012044520A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013003551A (es) * 2010-09-30 2013-05-01 Boehringer Ingelheim Int Formas en estado solido de un potente inhibidor del vch.
SI2787998T1 (sl) * 2011-12-06 2017-02-28 Sanofi Kristalinične oblike 2-(2-metilamino-pirimidin-4-il)-1H-indol-5-karboksilne kisline ((S)-1- karbamoil-2-(fenil-pirimidin-2-il-amino)etil)-amida
US20130261134A1 (en) * 2012-03-30 2013-10-03 Boehringer Ingelheim International Gmbh Mesylate salt forms of a potent hcv inhibitor
WO2014138374A1 (en) 2013-03-08 2014-09-12 Boehringer Ingelheim International Gmbh Oral combination therapy for treating hcv infection in specific patient sub-population

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0649651B1 (en) 1993-09-28 2000-12-13 R.P. Scherer GmbH Soft gelatin capsule manufacture
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
KR20120091276A (ko) 2004-02-20 2012-08-17 베링거 인겔하임 인터내셔날 게엠베하 바이러스 폴리머라제 억제제
US7642352B2 (en) 2005-02-11 2010-01-05 Boehringer Ingelheim International Gmbh Process for preparing 2,3-disubstituted indoles
RU2430719C2 (ru) 2005-11-09 2011-10-10 Новартис Аг Способ приготовления фармацевтических композиций с нестойким пластификатором
MX2013003551A (es) * 2010-09-30 2013-05-01 Boehringer Ingelheim Int Formas en estado solido de un potente inhibidor del vch.

Also Published As

Publication number Publication date
MA34548B1 (fr) 2013-09-02
CO6700844A2 (es) 2013-06-28
ECSP13012552A (es) 2013-06-28
AP2013006733A0 (en) 2013-02-28
CA2813179A1 (en) 2012-04-05
MX2013003551A (es) 2013-05-01
UY33632A (es) 2012-04-30
EP2621921A1 (en) 2013-08-07
US20140057928A1 (en) 2014-02-27
EA201300422A1 (ru) 2013-09-30
BR112013007700A2 (pt) 2019-09-24
PE20131351A1 (es) 2013-12-04
WO2012044520A1 (en) 2012-04-05
JP2013543495A (ja) 2013-12-05
AR083256A1 (es) 2013-02-13
TW201307327A (zh) 2013-02-16
CN103153987A (zh) 2013-06-12
SG188376A1 (en) 2013-04-30
KR20130108326A (ko) 2013-10-02
AU2011307346A1 (en) 2013-02-21
US20120122887A1 (en) 2012-05-17
US8598183B2 (en) 2013-12-03

Similar Documents

Publication Publication Date Title
BR112012012584A2 (pt) "processo para preparar sais de 4,5-diidroisoxazol-3-tiocarboxamidina 5,5-dissubstituídos de fórmula (i)"
FR2982610B1 (fr) Procede de preparation de sel d'anion pentacylique
PT2512474E (pt) Derivados de ácido hidroxâmico n-ligado úteis como agentes antibacterianos
DK2501683T3 (da) Substituerede carbamoylmethylaminoeddikesyrederivater som nye NEP-inhibitorer
IL223813A0 (en) Process for preparation of optically active diamine derivative salt
EA201270216A1 (ru) Фармацевтический состав
HU1000069D0 (en) New salts for the preparation of pharmaceutical composition
PE20140831A1 (es) Nuevo derivado de 1,2,3,4-tetrahidroquinolina util para el tratamiento de diabetes
FR2958291B1 (fr) Procede de preparation de derives d'amino-benzofurane
FR2961205B1 (fr) Procede de preparation de composes esteramides
PH12014502453A1 (en) Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)- chromen-4-one derivatives and their use in preparing pharmaceuticals
WO2013014665A8 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
FR2983316B1 (fr) Procede de preparation d'une lentille ophtalmique
CL2013000578A1 (es) Sal cristalina de sodio del acido (e)-3-[2-(1-{[2-(5-bromo-pririmidin-2-il)-3-ciclopentil-1-metil-1h-indol-6-carbonil]-amino}-ciclobutil)-3-metil-3h-bencimidazol-5-il]-acrilico: sal amorfa;compuestos intermediarios; procedimientos de preparacion; composicion farmaceutica.
CL2011002345A1 (es) Proceso de obtencion del acido (s)-2-metoxi-3-{4-[2-(5-metil-2-fenil-oxazol-4-il)-etoxi]-benzo[b]tiofen-7-il}-propionico utilizando un catalizador de iridio.
FR2966150B1 (fr) Procede de preparation de la 2-hydroxybutyrolactone
HRP20150875T1 (hr) Zahvatna jedinica za glave strojeva za žetvu
FR2939795B1 (fr) Procede de preparation d'esters actives
FR2977585B1 (fr) Procede de preparation d'esters
FR2999180B1 (fr) Procede de preparation de sels d'imidazolium dissymetriques
ITMI20120351A1 (it) Procedimento per la produzione di bicarbonato di sodio
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
FR2993556B1 (fr) Procede de preparation d'un compose sulfonimide et de ses sels
FR2969618B1 (fr) Procede de preparation de chondroitine sulfate de sodium
EP2575465A4 (en) Raltegravir SALTS